Ong SG, Ming LC, Lee KS, Yuen KH
Neurology is particularly high stakes: the EVOKE and EVOKE+ Phase 3 trials of semaglutide in early Alzheimers disease, due in 202526, will be the first large-scale cognitive readouts
The CoM patent on the CAR construct is important, but the commercially decisive IP is the manufacturing process itself the specific lentiviral or retroviral vector design, the transduction efficiency optimization, the T cell expansion protocol, the cryopreservation process, and the release assay specifications that determine product quality and clinical consistency
Explore the benefits and results of glutathione IV therapy for brighter skin, enhanced energy, and effective detoxification